Global insurer Chubb Limited prepares to release its fourth-quarter financial results after Tuesday's market close, with investors weighing solid peer performances against broader sector headwinds.
While Italtile's stock saw an 11% bump last month, a look at the past five years reveals a sobering picture for long-term investors, with total shareholder returns deep in negative territory even as company earnings grew.
Japan's financial giant Nomura Holdings is scaling back risk at its digital asset unit following Q3 losses, a strategic pullback that mirrors wider pain across the crypto treasury sector as Bitcoin struggles to hold key levels.
The traditional rulebook for dining during economic stress is obsolete. As a K-shaped recovery widens the gap between income groups, fast-food giants are struggling with deep discounts while casual dining chains unexpectedly thrive by redefining value.
A Beijing court has sentenced ex-Justice Minister Tang Yijun to life imprisonment on bribery charges, state media reported Monday, marking one of the highest-profile convictions in China's ongoing anti-corruption campaign.
Russian forces have reportedly seized the settlement of Prydorozhnie in southeastern Ukraine's Zaporizhzhia region, according to a defense ministry statement. The claim, yet to be independently verified, marks the latest in a series of incremental territorial gains.
As a Utah murder trial resumes, defense attorneys are pressing to remove the entire county prosecutor's office from the case, arguing the presence of a lead attorney's child at the crime scene creates an untenable conflict. Legal experts weigh the high bar for such motions.
As AI spending surges, investors face a classic choice: TSMC, the indispensable manufacturer powering the entire industry, or AMD, the aggressive designer aiming to dethrone Nvidia. We analyze the risk-reward calculus.
Initial drill results from the Senneville gold-silver-copper property in Quebec's prolific Val-d'Or camp have intersected significant near-surface mineralization, with intervals up to 57.8 meters, marking a promising start to the multi-phase exploration campaign.
A new forecast reveals streaming platforms are set to increase sports rights spending by 7% in 2026, with Amazon's Prime Video overtaking DAZN as the top investor, signaling a major shift in the battle for live sports dominance.
Shares of Tokio Marine Holdings (TSE:8766) have shown mixed performance recently, prompting investors to reassess the insurer's valuation amid a strong long-term track record. Analysts see potential upside from current levels, but risks remain.
Despite outperforming key benchmarks, APA Corporation faces a wall of analyst skepticism. With shares already trading above the average price target, the energy producer's disciplined strategy collides with muted expectations for near-term gains.
While trading near 52-week highs can signal strength, it can also precede a correction. We examine three stocks where current valuations may not justify the price tag, urging investors to look beyond the hype.
CrossCurve's cross-chain bridge was exploited on February 2, leading to an estimated $3 million loss. The incident underscores the recurring security challenges within decentralized finance's bridging infrastructure.
Ethereum's price has plunged 27% in five days, bringing it perilously close to the $2,000 threshold. While fear-driven selling dominates, on-chain metrics suggest the sell-off may be nearing exhaustion, potentially setting the stage for a long-term recovery.
New Gold Inc. shareholders have overwhelmingly approved the planned acquisition by Coeur Mining, a move set to create a leading, diversified precious metals producer focused entirely in North America. The deal, valued through a share swap, is anticipated to close in mid-2026.
Cogent Biosciences secures a key FDA Breakthrough Therapy Designation for its bezuclastinib-sunitinib combination in advanced GIST, following promising Phase 3 data that showed a halving of disease progression risk.
Terns Pharmaceuticals has restructured a key licensing deal with China's Hansoh, gaining exclusive worldwide rights for its TERN-701 oncology drug outside Greater China. The strategic move, coupled with a recent analyst price target surge, signals the company's aggressive push into international markets.
Audius SE (FRA:3ITN) shares jumped 13% last week, prompting a closer look at whether the rally is backed by the company's financial health or driven by broader market sentiment.
A $100 investment in Nvidia stock a decade ago would now be worth over $27,000, illustrating one of the most remarkable growth stories in modern market history, driven by the company's pivotal role in the AI revolution.
